发布求助
文献互助 智能选刊 最新文献

Im Fokus Onkologie最新文献

筛选
英文 中文
Einfacher Fragebogen erleichtert geriatrisches Assessment 简易问卷有助于老年病学评估
Im Fokus Onkologie Pub Date : 2024-02-01 DOI: 10.1007/s15015-024-3733-5
T. Müller
{"title":"Einfacher Fragebogen erleichtert geriatrisches Assessment","authors":"T. Müller","doi":"10.1007/s15015-024-3733-5","DOIUrl":"https://doi.org/10.1007/s15015-024-3733-5","url":null,"abstract":"","PeriodicalId":13436,"journal":{"name":"Im Fokus Onkologie","volume":null,"pages":null},"PeriodicalIF":0.0,"publicationDate":"2024-02-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"139685440","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
DLBCL: „Immune priming“ mit Avelumab und Rituximab vor Beginn der R-CHOP-Therapie DLBCL：在开始 R-CHOP 治疗前使用阿维列单抗和利妥昔单抗进行 "免疫初始化"
Im Fokus Onkologie Pub Date : 2024-02-01 DOI: 10.1007/s15015-023-3714-0
B. Schalhorn
{"title":"DLBCL: „Immune priming“ mit Avelumab und Rituximab vor Beginn der R-CHOP-Therapie","authors":"B. Schalhorn","doi":"10.1007/s15015-023-3714-0","DOIUrl":"https://doi.org/10.1007/s15015-023-3714-0","url":null,"abstract":"","PeriodicalId":13436,"journal":{"name":"Im Fokus Onkologie","volume":null,"pages":null},"PeriodicalIF":0.0,"publicationDate":"2024-02-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"139685596","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
Ösophaguskarzinom nach Radiochemotherapie zeitnah operieren 放化疗后及时手术治疗食道癌
Im Fokus Onkologie Pub Date : 2024-02-01 DOI: 10.1007/s15015-023-3718-9
D. Kraus
{"title":"Ösophaguskarzinom nach Radiochemotherapie zeitnah operieren","authors":"D. Kraus","doi":"10.1007/s15015-023-3718-9","DOIUrl":"https://doi.org/10.1007/s15015-023-3718-9","url":null,"abstract":"","PeriodicalId":13436,"journal":{"name":"Im Fokus Onkologie","volume":null,"pages":null},"PeriodicalIF":0.0,"publicationDate":"2024-02-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"139687728","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
Nach Hochdosis-Carboplatin: Veranlassen Sie einen Hörtest! 大剂量卡铂后：安排听力测试！
Im Fokus Onkologie Pub Date : 2024-02-01 DOI: 10.1007/s15015-023-3704-2
N. Zink
{"title":"Nach Hochdosis-Carboplatin: Veranlassen Sie einen Hörtest!","authors":"N. Zink","doi":"10.1007/s15015-023-3704-2","DOIUrl":"https://doi.org/10.1007/s15015-023-3704-2","url":null,"abstract":"","PeriodicalId":13436,"journal":{"name":"Im Fokus Onkologie","volume":null,"pages":null},"PeriodicalIF":0.0,"publicationDate":"2024-02-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"139688087","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
Verschreiben Sie Ihren Patientinnen und Patienten digitale Gesundheitsanwendungen? 您会给患者开数字健康应用处方吗？
Im Fokus Onkologie Pub Date : 2024-02-01 DOI: 10.1007/s15015-024-3754-0
Redaktion Facharztmagazine
{"title":"Verschreiben Sie Ihren Patientinnen und Patienten digitale Gesundheitsanwendungen?","authors":"Redaktion Facharztmagazine","doi":"10.1007/s15015-024-3754-0","DOIUrl":"https://doi.org/10.1007/s15015-024-3754-0","url":null,"abstract":"","PeriodicalId":13436,"journal":{"name":"Im Fokus Onkologie","volume":null,"pages":null},"PeriodicalIF":0.0,"publicationDate":"2024-02-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"139684975","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
r/r MM: Langzeitdaten zur Anti-CD38-Therapie mit Isatuximab r/r型MM：伊沙妥昔单抗抗CD38疗法的长期数据
Im Fokus Onkologie Pub Date : 2024-02-01 DOI: 10.1007/s15015-023-3703-3
J. Neumaier
{"title":"r/r MM: Langzeitdaten zur Anti-CD38-Therapie mit Isatuximab","authors":"J. Neumaier","doi":"10.1007/s15015-023-3703-3","DOIUrl":"https://doi.org/10.1007/s15015-023-3703-3","url":null,"abstract":"","PeriodicalId":13436,"journal":{"name":"Im Fokus Onkologie","volume":null,"pages":null},"PeriodicalIF":0.0,"publicationDate":"2024-02-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"139685785","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
Durchfall beim Säugling: War der Checkpointinhibitor der Mutter schuld? 婴儿腹泻：母亲服用的检查点抑制剂是罪魁祸首吗？
Im Fokus Onkologie Pub Date : 2024-02-01 DOI: 10.1007/s15015-023-3705-1
E. Oberhofer
{"title":"Durchfall beim Säugling: War der Checkpointinhibitor der Mutter schuld?","authors":"E. Oberhofer","doi":"10.1007/s15015-023-3705-1","DOIUrl":"https://doi.org/10.1007/s15015-023-3705-1","url":null,"abstract":"","PeriodicalId":13436,"journal":{"name":"Im Fokus Onkologie","volume":null,"pages":null},"PeriodicalIF":0.0,"publicationDate":"2024-02-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"139686877","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
Mit Telemedizin die Dyspnoe-Inaktivitäts-Spirale nach Lungenkrebs durchbrechen 利用远程医疗打破肺癌术后呼吸困难-活动障碍的恶性循环
Im Fokus Onkologie Pub Date : 2024-02-01 DOI: 10.1007/s15015-024-3738-0
Marie-Thérèse Weitzl
{"title":"Mit Telemedizin die Dyspnoe-Inaktivitäts-Spirale nach Lungenkrebs durchbrechen","authors":"Marie-Thérèse Weitzl","doi":"10.1007/s15015-024-3738-0","DOIUrl":"https://doi.org/10.1007/s15015-024-3738-0","url":null,"abstract":"","PeriodicalId":13436,"journal":{"name":"Im Fokus Onkologie","volume":null,"pages":null},"PeriodicalIF":0.0,"publicationDate":"2024-02-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"139687334","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
Gute Ergebnisse für chemofreie Erhaltungstherapie beim TNBC TNBC 免化疗维持疗法效果良好
Im Fokus Onkologie Pub Date : 2024-02-01 DOI: 10.1007/s15015-024-3724-6
Katharina Arnheim
{"title":"Gute Ergebnisse für chemofreie Erhaltungstherapie beim TNBC","authors":"Katharina Arnheim","doi":"10.1007/s15015-024-3724-6","DOIUrl":"https://doi.org/10.1007/s15015-024-3724-6","url":null,"abstract":"","PeriodicalId":13436,"journal":{"name":"Im Fokus Onkologie","volume":null,"pages":null},"PeriodicalIF":0.0,"publicationDate":"2024-02-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"139687454","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
Vierfachtherapie bald Standard beim neu diagnostizierten multiplen Myelom? 四联疗法即将成为新诊断多发性骨髓瘤的标准疗法？
Im Fokus Onkologie Pub Date : 2024-02-01 DOI: 10.1007/s15015-024-3730-8
F. Klein
{"title":"Vierfachtherapie bald Standard beim neu diagnostizierten multiplen Myelom?","authors":"F. Klein","doi":"10.1007/s15015-024-3730-8","DOIUrl":"https://doi.org/10.1007/s15015-024-3730-8","url":null,"abstract":"","PeriodicalId":13436,"journal":{"name":"Im Fokus Onkologie","volume":null,"pages":null},"PeriodicalIF":0.0,"publicationDate":"2024-02-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"139685999","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
首页 上一页 下一页 尾页
0
×
引用
GB/T 7714-2015
复制
MLA
复制
APA
复制
导出至
BibTeX EndNote RefMan NoteFirst NoteExpress
×
提示
您的信息不完整，为了账户安全，请先补充。
现在去补充
×
提示
您因"违规操作"
具体请查看互助需知
我知道了
×
提示
现在去查看 取消
×
提示
确定
请完成安全验证×
相关产品
×
本文献相关产品
联系我们：info@booksci.cn Book学术提供免费学术资源搜索服务，方便国内外学者检索中英文文献。致力于提供最便捷和优质的服务体验。 Copyright © 2023 布克学术 All rights reserved.
京ICP备2023020795号-1
ghs 京公网安备 11010802042870号
Book学术文献互助
Book学术文献互助群
群 号：481959085
Book学术官方微信